Literature DB >> 1973938

Abuse potential of buspirone and related drugs.

R L Balster1.   

Abstract

Scientific evidence regarding the drug abuse potential of buspirone and gepirone is reviewed. In animal studies, the pharmacologic profile of buspirone differs from that of other classes of abused drugs. Buspirone does not share discriminative stimulus effects with abused depressants, and it is not self-administered. New data are presented showing a lack of reinforcing effects for gepirone in rhesus monkeys when the drug was evaluated in an intravenous drug self-administration procedure. Studies of the acute effects of buspirone conducted in human subjects provide no evidence of abuse potential, and there is no indication that the drug has been abused to any extent since being marketed in December 1986. Available evidence suggests that the azapirones buspirone and gepirone have little, if any, potential for abuse.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1973938     DOI: 10.1097/00004714-199006001-00007

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  9 in total

Review 1.  5-HT1A partial agonists. What is their future?

Authors:  D A Glitz; R Pohl
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

2.  Fos after single and repeated self-administration of cocaine and saline in the rat: emphasis on the Basal forebrain and recalibration of expression.

Authors:  Daniel S Zahm; Mary L Becker; Alexander J Freiman; Sara Strauch; Beth Degarmo; Stefanie Geisler; Gloria E Meredith; Michela Marinelli
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

3.  Preference for diazepam, but not buspirone, in moderate drinkers.

Authors:  S M Evans; R R Griffiths; H de Wit
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

4.  Molecular dynamics of 5-HT1A and 5-HT2A serotonin receptors with methylated buspirone analogues.

Authors:  A Bronowska; Z Chilmonczyk; A Leś; O Edvardsen; R Ostensen; I Sylte
Journal:  J Comput Aided Mol Des       Date:  2001-11       Impact factor: 3.686

5.  Effects of buspirone and gepirone on i.v. cocaine self-administration in rhesus monkeys.

Authors:  L H Gold; R L Balster
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Effects of chronic buspirone treatment on cocaine self-administration.

Authors:  Nancy K Mello; Peter A Fivel; Stephen J Kohut; Jack Bergman
Journal:  Neuropsychopharmacology       Date:  2012-10-17       Impact factor: 7.853

7.  Prominent activation of brainstem and pallidal afferents of the ventral tegmental area by cocaine.

Authors:  Stefanie Geisler; Michela Marinelli; Beth Degarmo; Mary L Becker; Alexander J Freiman; Mitch Beales; Gloria E Meredith; Daniel S Zahm
Journal:  Neuropsychopharmacology       Date:  2007-12-19       Impact factor: 7.853

8.  Buspirone reduces sexual risk-taking intent but not cocaine self-administration.

Authors:  B Levi Bolin; Joshua A Lile; Katherine R Marks; Joshua S Beckmann; Craig R Rush; William W Stoops
Journal:  Exp Clin Psychopharmacol       Date:  2016-06       Impact factor: 3.157

9.  Preclinical Abuse Potential Assessment of Flibanserin: Effects on Intracranial Self-Stimulation in Female and Male Rats.

Authors:  Matthew F Lazenka; Bruce E Blough; S Stevens Negus
Journal:  J Sex Med       Date:  2016-01-28       Impact factor: 3.802

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.